DRRX

Durect Corporation News Headlines

$1.56
*  
0.01
0.65%
Get DRRX Alerts
*Delayed - data as of Jul. 22, 2014  -  Find a broker to begin trading DRRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    DRRX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month
7/2/2014 8:30:00 AM - Seeking Alpha

Durect Shares Should Double In The Next Year
5/3/2014 7:30:00 AM - Seeking Alpha

10 Reasons To Buy Durect Right Now
2/13/2014 10:45:00 AM - Seeking Alpha

Risk/Reward Remains Positive For Durect
11/5/2013 9:18:00 AM - Seeking Alpha

Pfizer: What Will Drive The Behemoth Forward?
10/31/2013 4:34:00 PM - Seeking Alpha

Pacira Pharmaceuticals: Slow And Steady Wins The Race
9/27/2013 5:52:00 PM - Seeking Alpha

IntelliPharmaCeutics - Primed For An Easy Double
8/22/2013 6:07:00 AM - Seeking Alpha

Market Wrap for Friday, August 16: Pullback In Equities Continues To Close Week
8/16/2013 5:17:34 PM - Benzinga

Healthcare Stocks Falling Near Close; Pain Therapeutics Soars After Pfizer Restarts Trial of New Pain-Killer
8/16/2013 3:55:32 PM - MT Newswires

Sector Update: Healthcare
8/16/2013 3:50:29 PM - MT Newswires

Pfizer Starts New Remoxy Trial - Outlook Bullish For Durect And Pain Therapeutics
8/16/2013 2:11:00 PM - Seeking Alpha

A Busy Next 6 Months For Durect Corp.
8/6/2013 12:57:00 PM - Seeking Alpha

FDA Decisions: Interesting Biotechnology Catalyst Events
7/9/2013 11:04:00 AM - Seeking Alpha

Healthcare Sector Down 2%; Durect Surges After FDA Accepts Prospective Post-Op Pain-Reliever For Review
6/20/2013 12:45:53 PM - MT Newswires

Sector Update: Healthcare
6/20/2013 12:32:20 PM - MT Newswires

Sector Update: Healthcare Shares Slide in Pre-Market; PTC Therapeutics Launches IPO at $15 Per Share
6/20/2013 8:39:09 AM - MT Newswires

Sector Update: Healthcare
6/20/2013 8:36:29 AM - MT Newswires

Alkermes Changing The Standard Of Care For Schizophrenia
6/13/2013 4:06:00 PM - Seeking Alpha

SmithOnStocks Opines Week Of June 2, 2013
6/3/2013 7:00:00 AM - Seeking Alpha

FDA Painkiller Abuse Concerns Creating Opportunity For Pfizer
5/20/2013 9:30:00 AM - Seeking Alpha

Mid-Day Update: Most Market Indices Turn Lower Again In Recent Minutes as Stock Fight to Maintain Direction
5/10/2013 12:23:15 PM - MT Newswires

Mid-Morning Market Update: Gold Futures See Sharp Decline, Ubiquity Networks Reports Growth for Second Straight Quarter
5/10/2013 10:47:14 AM - Benzinga

Durect: Pfizer Hints At Progress With Remoxy
5/3/2013 10:47:00 AM - Seeking Alpha

Pfizer's Efforts Boost Pain Therapeutics And Durect Corp.
5/2/2013 8:05:00 AM - Seeking Alpha

Why Did Pain Therapeutics Increase Over 25%?
5/2/2013 1:15:00 AM - Seeking Alpha